Schedule of Segment Reporting Information, by Segment |
The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below. | | | | | | | | |
|
| Cannabis and Medical Marijuana Segment
|
| Legacy Investment
|
| Corporate and Eliminations
|
| Consolidated
|
Three months ended March 2015
|
|
|
|
|
|
|
|
|
Net sales
| $
| -
| $
| 573 850
| $
| -
| $
| 573,850
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
| -
|
| 55 462
|
| (245,316)
|
| (183,317)
|
|
|
|
|
|
|
|
|
|
Total assets
|
| 1,626,740
|
| 1,114,834
|
| 1,140,954
|
| 3,882,528
|
|
|
|
|
|
|
|
|
|
Interest expense
|
| -
|
| 4,774
|
| (774)
|
| 4,000
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
| -
|
| 6,810
|
| 683
|
| 7,493
|
|
|
|
|
|
|
|
|
|
Three months ended March 2014
|
|
|
|
|
|
|
|
|
Net sales
| $
| -
| $
| 490,808
| $
| -
| $
| 490,808
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
| (21,551)
|
| 68,035
|
| (136,953)
|
| (90,469)
|
|
|
|
|
|
|
|
|
|
Total assets
|
| 1,600,927
|
| 1,122,564
|
| 1,270,899
|
| 3,994,390
|
|
|
|
|
|
|
|
|
|
Interest expense
|
| -
|
| 4,093
|
| 397
|
| 4,490
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
| -
|
| 6,091
|
| 3,369
|
| 9,460
|
|